INOVIO PHARMACEUTICALS, INC. Sales Agreements
6 Contracts & Agreements
- ATM Equity OfferingSM Sales Agreement dated November 9, 2021 by and among Inovio Pharmaceuticals, Inc., BofA Securities, Inc., RBC Capital Markets, LLC and Oppenheimer & Co. Inc (Filed With SEC on November 9, 2021)
- At-The-Market Equity Offering Sales Agreement dated April 3, 2020 between Inovio Pharmaceuticals, Inc. and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on April 3, 2020)
- Amendment No. 2 to the At-The-Market Equity Offering Sales Agreement dated March 9, 2020 between Inovio Pharmaceuticals, Inc. and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on March 9, 2020)
- Amendment No. 1 to the At-The-Market Equity Offering Sales Agreement dated February 7, 2020 between Inovio Pharmaceuticals, Inc. and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on February 7, 2020)
- At-the-Market Equity Offering Sales Agreement dated May 25, 2018 between Inovio Pharmaceuticals, Inc. and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on May 25, 2018)
- INOVIO PHARMACEUTICALS, INC. $25,000,000 SALES AGREEMENT (Filed With SEC on June 1, 2012)
